Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-03-01 @ 6:01 AM
Study NCT ID:
NCT01542918
Status:
COMPLETED
Last Update Posted:
2020-08-11
First Post:
2012-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma
Sponsor:
James Rubenstein
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-27
First Submit QC Date:
None
Study First Post Date:
2012-03-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-07
Last Update Post Date:
2020-08-11
Last Update Post Date Type:
ACTUAL